BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14646625)

  • 1. Treatment of locoregional metastases of malignant melanomas with radiotherapy and intralesional beta-interferon injection.
    Paul E; Müller I; Renner H; Bödeker RH; Cochran AJ
    Melanoma Res; 2003 Dec; 13(6):611-7. PubMed ID: 14646625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intralesional therapy of melanoma metastases with recombinant interferon-beta].
    Fierlbeck G; d'Hoedt B; Stroebel W; Stutte H; Bogenschütz O; Rassner G
    Hautarzt; 1992 Jan; 43(1):16-21. PubMed ID: 1612904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional therapy of metastatic spreading melanoma with beta-interferon.
    Rapprich H; Hagedorn M
    J Dtsch Dermatol Ges; 2006 Sep; 4(9):743-6. PubMed ID: 16928243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Significant survival advantage in 96 treated patients in comparison with 288 untreated symptomatic controls].
    Beiteke U; Ruppert P; Garbe C; Oxenfarth R; Kastl I; Türker T; Tronnier H; Frosch PJ
    Hautarzt; 1993 Jun; 44(6):365-71. PubMed ID: 8335459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma.
    Mastrangelo MJ; Maguire HC; Eisenlohr LC; Laughlin CE; Monken CE; McCue PA; Kovatich AJ; Lattime EC
    Cancer Gene Ther; 1999; 6(5):409-22. PubMed ID: 10505851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiotherapy of malignant melanoma of the skin].
    Suter L; Fuhrmann D
    Praxis (Bern 1994); 2001 Mar; 90(10):397-402. PubMed ID: 11305185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan.
    Wada H; Nemoto K; Ogawa Y; Hareyama M; Yoshida H; Takamura A; Ohmori K; Hamamoto Y; Sugita T; Saitoh M; Yamada S
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):495-500. PubMed ID: 15145168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cases of metastatic malignant melanoma of the lower limb treated with hyperthermic isolated limb perfusion and concomitant infusion of either carboplatin or beta-interferon.
    Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y
    J Dermatol; 1996 Jan; 23(1):6-15. PubMed ID: 8720252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma.
    Hancock BW; Wheatley K; Harris S; Ives N; Harrison G; Horsman JM; Middleton MR; Thatcher N; Lorigan PC; Marsden JR; Burrows L; Gore M
    J Clin Oncol; 2004 Jan; 22(1):53-61. PubMed ID: 14665609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
    Maruoka M; Fujimura M; Kawamura K; Suzuki S; Hamano M; Nishikawa Y; Nagayama T
    Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma.
    Stopeck AT; Jones A; Hersh EM; Thompson JA; Finucane DM; Gutheil JC; Gonzalez R
    Clin Cancer Res; 2001 Aug; 7(8):2285-91. PubMed ID: 11489803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perilesional treatment of metastatic melanoma with interferon-beta.
    Fujimura T; Okuyama R; Ohtani T; Ito Y; Haga T; Hashimoto A; Aiba S
    Clin Exp Dermatol; 2009 Oct; 34(7):793-9. PubMed ID: 19438554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
    Ballo MT; Zagars GK; Gershenwald JE; Lee JE; Mansfield PF; Kim KB; Camacho LH; Hwu P; Ross MI
    Ann Surg Oncol; 2004 Dec; 11(12):1079-84. PubMed ID: 15576833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of metastatic malignant melanoma with recombinant interferon alpha 2.
    Robinson WA; Mughal TI; Thomas MR; Johnson M; Spiegel RJ
    Immunobiology; 1986 Sep; 172(3-5):275-82. PubMed ID: 3804370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma.
    Richtig E; Ludwig R; Kerl H; Smolle J
    Br J Dermatol; 2005 Nov; 153(5):925-31. PubMed ID: 16225601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
    Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
    Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.